Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
OBIO Stock — Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc. (OBIO)
Updated October 16, 2026.
OBIO is a Stock. Total return is -52.2% over the past 6.2 years, 203.9 points behind SPY at 151.7%.
Orchestra BioMed Holdings is a biomedical company developing therapeutic devices and drug-delivery systems focused on cardiovascular disease and gastrointestinal procedures. Its pipeline includes bioelectronic therapies for blood pressure and heart failure management, drug-coated balloon systems for arterial disease, and procedural devices including the Pure-Vu system for colonoscopy preparation; the company has partnerships with Medtronic and Terumo for product development and commercialization. The company does not currently have an established distribution schedule.
OBIO performance versus SPY
Price and return data through 2026-10-16.
Total return is -52.2% over the past 6.2 years, 203.9 points behind SPY at 151.7%. Over the past year its total return — price change plus distributions reinvested — is 48.1%. Its deepest 1-year drawdown was 34.8%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -9.3% | — |
| 3M | 46.5% | — |
| 6M | 21.9% | — |
| YTD | 31.3% | — |
| 1Y | 48.1% | — |
| 2Y CAGR | — | -1.90% |
| 3Y CAGR | — | -0.30% |
| 5Y CAGR | — | -11.20% |
| Since inception (6.2 years) | -52.2% | -11.20% |
OBIO key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 08/04/2020
- Distribution frequency
- None
- Last close
- $5.45 (as of 2026-10-16)
- Market cap
- $327,572,517
- Average volume
- 473700.0
- Beta
- 0.516
- Payout ratio
- 0.0%
- EPS
- $-0.86
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
OBIO risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 34.8%.
Who may consider OBIO — and who may not
It is a weaker fit for investors who need monthly cash flow (OBIO does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on OBIO
Frequently asked questions
Does OBIO pay monthly?
No. OBIO does not currently distribute.
When does OBIO pay a dividend?
OBIO does not currently distribute.
How has OBIO performed?
Total return is -52.2% over the past 6.2 years, 203.9 points behind SPY at 151.7%. Over the past year its total return — price change plus distributions reinvested — is 48.1%. Its deepest 1-year drawdown was 34.8%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.